JP Stock MarketDetailed Quotes

4896 K Pharma

Watchlist

745
+15+2.05%

20min DelayNoon Break Nov 25 10:42 JST

8.65BMarket Cap32.29P/E (Static)

K Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

Total revenue

Cost of revenue

90M

Gross profit

910M

Operating expense

192.7M

230.79M

53.75%543.94M

149.78M

135.27M

61.18%353.77M

219.49M

Operating profit

-192.7M

-230.79M

203.47%366.06M

-149.78M

-135.27M

-61.18%-353.77M

-219.49M

Net non-operating interest income (expenses)

14K

-118.44%-11.83M

-8.66M

-3.18M

-541,800.00%-5.42M

Non-operating interest income

--0

--14K

128.57%16K

--0

--9K

600.00%7K

--1K

Total other finance cost

----

118.46%11.85M

--8.66M

----

--5.42M

----

Net investment income

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

Income from associates and other participating interests

Special income (charges)

-580K

-2.1M

-37.75%-43.11M

-6.52M

-225.16%-31.29M

-9.62M

Less:Other special charges

----

--0

----

--1.4M

Less:Write off

--580K

--2.1M

37.75%43.11M

--6.61M

--0

280.42%31.29M

--8.23M

Other non-operating income (expenses)

-22,211.11%-10.04M

-6.04M

-1,025.00%-45K

-4K

Income before tax

-192.48M

-232.87M

177.09%301.08M

-171M

-142.46M

-70.45%-390.53M

-229.12M

Income tax

578K

579K

2,044.53%40.75M

-33.11M

-25.9M

575.00%1.9M

-400K

Net income

-193.06M

-233.45M

166.34%260.33M

-137.88M

-116.56M

-71.58%-392.43M

-228.72M

Net income continuous operations

---193.06M

---233.45M

166.34%260.33M

---137.88M

---116.56M

-71.58%-392.43M

---228.72M

Noncontrolling interests

Net income attributable to the company

-193.06M

-233.45M

166.34%260.33M

-137.88M

-116.56M

-71.58%-392.43M

-228.72M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-193.06M

-233.45M

166.34%260.33M

-137.88M

-116.56M

-71.58%-392.43M

-228.72M

Gross dividend payment

Basic earnings per share

-16.63

-20.12

160.44%25.42

-14.889

-11.7987

-112.55%-42.0577

-19.787

Diluted earnings per share

-16.6362

-20.12

154.85%23.07

-14.889

-11.7987

-112.55%-42.0577

-19.787

Dividend per share

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021
Total revenue	0	0	1B	0	0	0	0
Cost of revenue	0	0	90M	0	0	0
Gross profit	0	0	910M	0	0	0
Operating expense	192.7M	230.79M	53.75%543.94M	149.78M	135.27M	61.18%353.77M	219.49M
Operating profit	-192.7M	-230.79M	203.47%366.06M	-149.78M	-135.27M	-61.18%-353.77M	-219.49M
Net non-operating interest income (expenses)	0	14K	-118.44%-11.83M	-8.66M	-3.18M	-541,800.00%-5.42M	1K
Non-operating interest income	--0	--14K	128.57%16K	--0	--9K	600.00%7K	--1K
Total other finance cost	----	----	118.46%11.85M	--8.66M	----	--5.42M	----
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)	-580K	-2.1M	-37.75%-43.11M	-6.52M	0	-225.16%-31.29M	-9.62M
Less:Other special charges	----	----	----	----	--0	----	--1.4M
Less:Write off	--580K	--2.1M	37.75%43.11M	--6.61M	--0	280.42%31.29M	--8.23M
Other non-operating income (expenses)			-22,211.11%-10.04M	-6.04M		-1,025.00%-45K	-4K
Income before tax	-192.48M	-232.87M	177.09%301.08M	-171M	-142.46M	-70.45%-390.53M	-229.12M
Income tax	578K	579K	2,044.53%40.75M	-33.11M	-25.9M	575.00%1.9M	-400K
Net income	-193.06M	-233.45M	166.34%260.33M	-137.88M	-116.56M	-71.58%-392.43M	-228.72M
Net income continuous operations	---193.06M	---233.45M	166.34%260.33M	---137.88M	---116.56M	-71.58%-392.43M	---228.72M
Noncontrolling interests
Net income attributable to the company	-193.06M	-233.45M	166.34%260.33M	-137.88M	-116.56M	-71.58%-392.43M	-228.72M
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0
Net income attributable to common stockholders	-193.06M	-233.45M	166.34%260.33M	-137.88M	-116.56M	-71.58%-392.43M	-228.72M
Gross dividend payment
Basic earnings per share	-16.63	-20.12	160.44%25.42	-14.889	-11.7987	-112.55%-42.0577	-19.787
Diluted earnings per share	-16.6362	-20.12	154.85%23.07	-14.889	-11.7987	-112.55%-42.0577	-19.787
Dividend per share
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data